Prescribing Information Cerebrolysin®

Abbreviated Prescribing Information - Cerebrolysin®


This information is based on the Austrian Summary of Product Characteristics. The prescribing information in your country may vary; please consult your local prescribing information and/or contact your local EVER representative.

To access the site for information on Cerebrolysin please confirm that you are a healthcare professional.

We are using cookies to provide statistics that help us give you the best experience of our site. You can find out more or switch them off if you prefer. However, by continuing to use the site without changing settings, you are agreeing to our use of cookies.

Name of the medicinal product: Cerebrolysin® - Solution for injection.
Qualitative and quantitative composition:One ml contains 215.2 mg of Cerebrolysin® concentrate in aqueous solution.
List of excipients:Sodium hydroxide and water for injection
Therapeutic indications: 

For treatment of cerebrovascular disorders.